Get startedLog in
    Picture of CSL logo

    CSL — CSL News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: CSL And Lilly Enter Licensing Agreement For Clazakizumab

    Picture of CSL logoCSL
    17/02/2026 21:19
    Feb 18 (Reuters) - CSL Ltd CSL.AX:

CSL AND LILLY ENTER LICENSING AGREEMENT FOR CLAZAKIZUMAB

EXCLUSIVE LICENSING AGREEMENT GRANTING CERTAIN RIGHTS TO DEVELOP AND COMMERCIALISE CLAZAKIZUMAB

CSL WILL RECEIVE AN UPFRONT PAYMENT OF $100 MILLION

CSL WILL RETAIN EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALISE CLAZAKIZUMAB FOR PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH END-STAGE KIDNEY DISEASE

Further company coverage: CSL.AX

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on CSL

    See all news